NCT04167189View on ClinicalTrials.gov

Observational Study to Assess the Frequency of Lidocaine Ineffectiveness in Hard-to-treat ADHD

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

January 20, 2018

Primary Completion Date

March 30, 2020

Study Completion Date

March 30, 2020

Conditions
ADHD
Interventions
DRUG

Lidocaine gel

Septodont 5% oral lidocaine gel (NDC 0362-0221-10), 75 mg

Trial Locations (1)

08043

NeurAbilitis, Voorhees Township

All Listed Sponsors
collaborator

NeurAbilities (formerly CRCNJ)

OTHER

lead

PhenoSolve, LLC

INDUSTRY

NCT04167189 - Observational Study to Assess the Frequency of Lidocaine Ineffectiveness in Hard-to-treat ADHD | Biotech Hunter | Biotech Hunter